Beodeul Kang
Overview
Explore the profile of Beodeul Kang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
720
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sung M, Shin S, Kwon C, Kang I, Lee S, Yang S, et al.
Sci Rep
. 2025 Jan;
15(1):3654.
PMID: 39880870
The recent clinical outcomes of multi-regimen chemotherapy included prolonged survival and a high rate of conversion to surgery in Asian patients with advanced biliary tract cancer. The ability of single-operator...
2.
Kim I, Kang S, Choi W, Seo A, Eom B, Kang B, et al.
J Gastric Cancer
. 2025 Jan;
25(1):5-114.
PMID: 39822170
Gastric cancer is one of the most common cancers in both Korea and worldwide. Since 2004, the Korean Practice Guidelines for Gastric Cancer have been regularly updated, with the 4th...
3.
Scheiner B, Kang B, Balcar L, Radu I, Reiter F, Adzic G, et al.
Hepatology
. 2024 Dec;
PMID: 39643944
Background And Aims: The outcome of patients with HCC who achieved complete response (CR) to immune-checkpoint inhibitor (ICI)-based systemic therapies is unclear. Approach And Results: Retrospective study of patients with...
4.
Lee S, Sung M, Shin S, Chon H, Kang B, Ko K, et al.
Gut Liver
. 2024 Nov;
18(6):1085-1089.
PMID: 39506309
Recent clinical outcomes of multi-regimen chemotherapy in patients with cholangiocarcinoma (CCC) have shown benefits in terms of overall survival. However, repeated endoscopic biliary drainage (EBD) and serious adverse events negatively...
5.
Hwang S, Woo S, Kang B, Kang H, Kim J, Lee S, et al.
J Hepatol
. 2024 Oct;
PMID: 39442892
Background & Aims: Recent advances in molecular profiling have enabled the identification of potential therapeutic targets for biliary tract cancer (BTC). However, in patients with BTC, molecular profiling is hindered...
6.
Jung E, Hiratsuka Y, Suh S, Yoon S, Kang B, Lee S, et al.
Palliat Med Rep
. 2024 Sep;
5(1):365-372.
PMID: 39281186
Background: Timely palliative transition in patients with advanced cancer is essential for their improved quality of life and overall survival (OS). Most prognostic models have been developed focusing on weeks'...
7.
Kim Y, Kim J, Kang B, Kim I, Kim H, Lee W, et al.
Cancer Res Treat
. 2024 May;
56(4):1231-1239.
PMID: 38810969
Purpose: Since 2020, atezolizumab plus bevacizumab (Ate/Bev) has been the standard first-line therapy for unresectable hepatocellular carcinoma (HCC), but long-term treatment studies are limited. This study evaluated the clinical characteristics...
8.
Lee J, Yoo I, Hong S, Kang B, Kim J, Kim Y, et al.
Biomedicines
. 2024 May;
12(5).
PMID: 38790906
2-Deoxy-2-[F]fluoro-d-glucose (FDG) uptake of the reticuloendothelial system on positron emission tomography/computed tomography (PET/CT) is known to be related to systemic inflammatory response to cancer cells in patients with diverse malignancies....
9.
Kim Y, Lee H, Woo H, Lee S, Hong M, Jung E, et al.
Sci Rep
. 2024 May;
14(1):11503.
PMID: 38769382
This study aimed to present a new approach to predict to delirium admitted to the acute palliative care unit. To achieve this, this study employed machine learning model to predict...
10.
Lee D, Lee S, Yoo S, Kim K, Kim M, Shin J, et al.
PLoS One
. 2024 May;
19(5):e0302011.
PMID: 38739589
Advancements in the treatment and management of patients with cancer have extended their survival period. To honor such patients' desire to live in their own homes, home-based supportive care programs...